Search Within

Saad Zafar Usmani

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (56)
  2. Journal Article (15)
  3. Research Letter (3)
  4. Correspondence (2)
Groups
  1. Epidemiology and Biostatistics (76)
  2. Department of Medicine (73)
  3. Hematologic Malignancies, Division of (73)
  4. Center for Hematologic Malignancies (71)
  5. Biostatistics Service (69)
  6. Myeloma (69)

More Groups

People
  1. Alexander Lesokhin (66)
  2. Urvi Shah (62)
  3. Kylee Maclachlan (59)
  4. Malin Hultcrantz (59)
  5. Sham Mailankody (59)
  6. Andriy Derkach (57)

More People

Years
  1. 2025 (3)
  2. 2024 (23)
  3. 2023 (30)
  4. 2022 (20)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (25)
  2. Blood (23)
  3. Journal of Clinical Oncology (10)
  4. Blood Cancer Journal (6)
  5. Blood Advances (3)
  6. New England Journal of Medicine (2)

More Publications

Publishers
  1. American Society of Hematology (26)
  2. Elsevier Inc. (26)
  3. American Society of Clinical Oncology (10)
  4. Nature Publishing Group (7)
  5. Massachusetts Medical Society (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets
    Journal Article

    Shah, U. A.; Maclachlan, K. H.; Derkach, A.; Salcedo, M.; Barnett, K.; Caple, J.; Blaslov, J.; Tran, L.; Ciardiello, A.; Burge, M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinical efficacy of daratumumab (DARA)-based second line therapy after DARAcontaining and DARA-free induction therapies in multiple myeloma: A single center experience
    Meeting Abstract

    Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Lu, S. X.; Patel, D.; Maclachlan, K.; Lahoud, O. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to White patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Evaluating serum-free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Nutrition perceptions, needs and practices among patients with plasma cell disorders
    Research Letter

    Malik, M. A.; Sweeney, N. W.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P. A.; Mailankody, S.; Korde, N.; Tan, C. R.; Hassoun, H.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save